Effect of Chronic Treatment with Lacidipine or Lisinopril on Intracellular Partitioning of Glucose Metabolism in Type 2 Diabetes Mellitus1
Enzo Bonora,
Giovanni Targher,
Maria Alberiche,
Riccardo C. Bonadonna,
Francesca Saggiani,
Marina B. Zenere,
Stefano Uleri and
Michele Muggeo
Division of Endocrinology and Metabolic Diseases, University of
Verona Medical School, and Medical Department, GlaxoWellcome (S.U.),
37126 Verona, Italy
Address all correspondence and requests for reprints to: Prof. Enzo Bonora, Endocrinologia e Malattie del Metabolismo, Ospedale Civile Maggiore, Piazzale Stefani 1, 37126 Verona, Italy. E-mail:
malmetab{at}borgotrento.univr.it
Antihypertensive treatment is frequently needed in type 2 diabetes.In
this study we measured the rates of total, oxidative, andnonoxidative
glucose disposal, glycogen synthesis, glycolysis,endogenous glucose
production, and lipid oxidation using a 4-heuglycemic (5 mmol/L)
hyperinsulinemic (300 pmol/L) clamp incombination with a dual
glucose tracer infusion ([3-3H]- and
[U-14C]D-glucose)and indirect calorimetry in
40 nonobese subjects with type 2diabetes. Subjects were studied twice:
after a 4-week run-inperiod and after a 16-week period of double
blind, randomizedtreatment with 46 mg/day lacidipine, a calcium
channelblocker (n = 19), or 1020 mg/day lisinopril, an
angiotensin-convertingenzyme inhibitor (n = 21). Antihypertensive
treatment resultedin a significant increase in total glucose disposal
during insulinclamp as well as in basal and insulin-stimulated
nonoxidativeglucose disposal rates. On the contrary, oxidative glucose
disposalwas significantly decreased by antihypertensive treatment,
mainlyin the basal state. The changes in glucose disposal rates were
notsignificantly different in subjects treated with lacidipineand in
those treated with lisinopril. The suppression of endogenousglucose
production during insulin clamp was significantly greaterafter
lacidipine than after lisinopril.
These results suggest that treatment of subjects with type 2diabetes
with either lacidipine or lisinopril has no adverseeffect on glucose
metabolism. Conversely, both drugs seem toimprove insulin sensitivity.
This article has been cited by other articles:
P. Schling and G. Loffler Cross Talk Between Adipose Tissue Cells: Impact on Pathophysiology
Physiology,
June 1, 2002;
17(3):
99 - 104.
[Abstract][Full Text][PDF]
G. Targher, R. C. Bonadonna, M. Alberiche, M. B. Zenere, M. Muggeo, and E. Bonora Relation Between Soluble Adhesion Molecules and Insulin Sensitivity in Type 2 Diabetic Individuals: Role of adipose tissue
Diabetes Care,
November 1, 2001;
24(11):
1961 - 1966.
[Abstract][Full Text][PDF]
E. Bonora, G. Targher, M. Alberiche, R. C. Bonadonna, M. B. Zenere, F. Saggiani, and M. Muggeo Intracellular Partition of Plasma Glucose Disposal in Hypertensive and Normotensive Subjects with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
May 1, 2001;
86(5):
2073 - 2079.
[Abstract][Full Text]